---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-22-000131"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2022-11-04T23:59:59+00:00"
generated_at: "2026-06-22T07:23:46.879494+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q1 FY23 revenue up 13% to $49.6B; GAAP EPS $0.40, non-GAAP EPS $1.20; Medical segment posts loss

## Summary
- GAAP operating earnings $137M, including $154M goodwill impairment; GAAP diluted EPS $0.40, down 57% YoY.
- Non-GAAP operating earnings $423M (-20% YoY); non-GAAP diluted EPS $1.20 (-7% YoY).
- Pharmaceutical segment profit up 6% to $431M; Medical segment loss of $8M vs $123M profit prior year.
- Revised FY23 Medical segment profit outlook to flat to 20% decline; reaffirms non-GAAP EPS guidance $5.05-$5.40.
- Updated FY23 interest/other expense to $140M-$160M, non-GAAP tax rate 23%-24%, diluted shares ~262-264M.

## SEC filing metadata
- accession: 0000721371-22-000131
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2022-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/0000721371-22-000131-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/cah-20221104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-22-000131
- JSON: https://secwatch.observer/filing/0000721371-22-000131.json
- Plain text: https://secwatch.observer/filing/0000721371-22-000131.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported the quarter ended September 30, 2022 results: revenue $49.6 billion, net income $110 million, EPS $0.40. Guidance reaffirmed.
  - Period: the quarter ended September 30, 2022
  - Revenue: $49.6 billion
  - Net income: $110 million
  - EPS: $0.40
  - Guidance: reaffirmed
  - Result: reported results
  source text: Cardinal Health Reports First Quarter Fiscal 2023 Results • Revenue increased 13% to $49.6 billion • GAAP 1 operating earnings were $137 million, GAAP diluted EPS were $0.40 • Non-GAAP operating earnings decreased 20% to $423 million due to a decline in Medical segment profit, partially offset by an increase in Pharmaceutical segment profit; non-GAAP diluted EPS decreased 7% to $1.20 • Company reaffirmed fiscal year 2023 non-GAAP EPS guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/0000721371-22-000131-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.